(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MM RC MULTIPLE MYELOMA RESEARCH CONSORTIUM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MM RC MULTIPLE MYELOMA RESEARCH CONSORTIUM

ST13

US500000098693972

Class

42, 44

Filing

98693972

Registration

7912419

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

08/27/2025

Trademark type

Combined

Nice classes

42, 44

Filing date

08/12/2024

Registration date

08/26/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/26/2025

Last transaction

08/27/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

2014-05-00

First use in commerce

2014-05-00

Drawing code

3

Owner type

99

Owner location

Norwalk, CT

Examiner

SCHMIDT, JOHN

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of two letters "M" above the letters "R" and "C" with a border surrounding the letters and is broken at the top let and bottom right corners with the words MULTIPLE MYELOMA RESEARCH CONSORTIUM to the right of the border.

Holders and representatives

Holders

The Multiple Myeloma Research Foundation, Inc.

Representatives

Jacqueline P. Scheib Robinson & Cole LLP

Technical classification

Nice Classes

Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medical and scientific research featuring the development of therapies and cures for multiple myeloma through scientific collaborationaccelerated research effortsthe advancement of technologies; and providing on-line information about medical research relating to multiple myeloma via global computer network.

Class 44

Providing medical information about the treatment of multiple myeloma via a global computer network.

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/26/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

08/26/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/08/2025

PUBO

PUBLISHED FOR OPPOSITION

07/08/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/02/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/05/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/05/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/05/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

06/05/2025

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

06/04/2025

GNFR

FINAL REFUSAL E-MAILED

06/04/2025

CNFR

FINAL REFUSAL WRITTEN

06/04/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/02/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/02/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/02/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/10/2025

GNRT

NON-FINAL ACTION E-MAILED

04/10/2025

CNRT

NON-FINAL ACTION WRITTEN

04/10/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/03/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/03/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/03/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/28/2025

GNRT

NON-FINAL ACTION E-MAILED

02/28/2025

CNRT

NON-FINAL ACTION WRITTEN

02/28/2025

DOCK

ASSIGNED TO EXAMINER

02/26/2025

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

02/25/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/25/2025

NWAP

NEW APPLICATION ENTERED

08/12/2024

Continuous trademark protection

Get notified about every new filing that threatens MM RC MULTIPLE MYELOMA RESEARCH CONSORTIUM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.